GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 35 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,687,000 | -12.8% | 61,732 | -12.8% | 0.79% | +30.4% |
| Q1 2022 | $3,082,000 | +7.2% | 70,762 | +8.6% | 0.61% | +0.5% |
| Q4 2021 | $2,874,000 | +15.8% | 65,177 | +0.4% | 0.60% | +16.3% |
| Q3 2021 | $2,481,000 | +4.8% | 64,931 | +9.2% | 0.52% | +7.4% |
| Q2 2021 | $2,367,000 | +24.1% | 59,441 | +11.2% | 0.48% | +4.1% |
| Q1 2021 | $1,907,000 | +23.0% | 53,436 | +26.8% | 0.46% | +13.1% |
| Q4 2020 | $1,551,000 | -4.4% | 42,143 | -6.0% | 0.41% | -11.0% |
| Q3 2020 | $1,622,000 | -12.2% | 44,830 | -1.0% | 0.46% | -27.6% |
| Q2 2020 | $1,848,000 | -7.8% | 45,293 | -3.6% | 0.64% | -24.7% |
| Q1 2020 | $2,004,000 | +12.8% | 47,001 | +24.4% | 0.85% | +37.1% |
| Q4 2019 | $1,776,000 | – | 37,796 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 668,200 | $30,717,000 | 9.01% |
| Camber Capital Management LP | 1,200,000 | $55,164,000 | 5.18% |
| Camber Capital Management LP | 1,000,000 | $45,970,000 | 4.32% |
| Gary Goldberg Planning Services Inc | 178,496 | $8,205,000 | 3.41% |
| Hamlin Capital Management, LLC | 1,217,870 | $55,985,000 | 3.36% |
| Winch Advisory Services, LLC | 109,101 | $5,015,000 | 3.22% |
| NORTHROAD CAPITAL MANAGEMENT LLC | 151,701 | $6,974,000 | 2.69% |
| Reynders McVeigh Capital Management, LLC | 296,118 | $13,613,000 | 2.59% |
| SALEM CAPITAL MANAGEMENT INC | 120,520 | $5,540,000 | 2.58% |
| Keystone Financial Planning, Inc. | 74,338 | $3,417,000 | 2.58% |